Related Experiment Video

Updated: Jul 7, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis

R A Eliseev1, Y-F Dong, E Sampson

  • 1Department of Orthopaedics, Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.

Oncogene
|January 29, 2008
PubMed

Insights

Runx2 transcription factor directly induces Bax expression, increasing apoptosis sensitivity in osteosarcoma cells. This Runx2-dependent regulation of Bax highlights its role as a proapoptotic factor in cancer.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Biology

Background:

  • The Runx family of transcription factors are crucial regulators of cell growth, differentiation, and fate.
  • Runx2, a bone-related Runx member, plays a significant role in skeletal development and is implicated in various cancers, including osteosarcoma.

Purpose of the Study:

  • To investigate the role of Runx2 in regulating apoptosis in osteosarcoma cells.
  • To determine if Runx2 modulates the expression of Bcl2 family genes, specifically Bax.
  • To elucidate the direct interaction between Runx2 and the human Bax promoter.

Main Methods:

  • Utilized the osteosarcoma cell line Saos2.
  • Performed experiments to assess Runx2 binding to the human Bax promoter.
  • Investigated the effects of bone morphogenetic protein-induced or vector-mediated Runx2 expression on Bax expression and apoptosis.
  • Employed Runx2 loss-of-function studies to confirm dependency.

Main Results:

  • Runx2 was found to directly bind to Runx-specific elements on the human Bax promoter, inducing Bax expression.
  • Increased Runx2 expression led to upregulation of Bax and enhanced sensitivity to apoptosis in Saos2 cells.
  • Runx2 loss of function abrogated the upregulation of Bax and the increase in apoptosis, confirming Runx2 dependency.

Conclusions:

  • Bax is identified as a direct transcriptional target of Runx2.
  • Runx2 acts as a proapoptotic factor in osteosarcoma cells by inducing Bax expression.
  • These findings suggest a potential therapeutic target for osteosarcoma treatment by modulating Runx2 activity.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...